COVID-19 mRNA疫苗接种后心肌炎患者血中检出游离刺突蛋白
该前瞻性研究纳入16例SARS-CoV-2疫苗接种后因心肌炎住院的青少年和年轻成人,并与45例健康无症状匹配接种者对照。结果发现心肌炎患者免疫 profiles 与对照基本无差异,但血浆中检出显著升高的全长刺突蛋白(33.9±22.4 pg/mL),而对照组未检出游离刺突蛋白(P<0.0001)。
要点
- mRNA疫苗接种后心肌炎患者免疫应答与无症状接种者无本质差异。
- 心肌炎患者血浆中检出游离全长刺突蛋白,对照组未检出。
- 游离刺突蛋白可能为疫苗相关心肌炎的潜在机制提供线索。
核心结论
- mRNA疫苗诱导的免疫应答在心肌炎患者与未发生心肌炎者之间无差异,但心肌炎患者血中可检出游离刺突抗原。
研究设计与样本
- 前瞻性收集2021年1月至2022年2月期间在两家儿童医院因SARS-CoV-2疫苗接种后心肌炎住院的16例患者血样,并与45例健康无症状年龄匹配的接种对照比较。
主要发现
- 心肌炎患者与对照的广泛抗体谱和T细胞应答基本无法区分,尽管细胞因子产生有轻度增加。
- 心肌炎患者血浆中全长刺突蛋白水平显著升高(33.9±22.4 pg/mL),且未被抗体结合,而对照未检出游离刺突蛋白(非配对t检验;P<0.0001)。
临床怎么用
- 对于mRNA疫苗接种后出现心肌炎的年轻患者,可考虑游离刺突蛋白作为潜在生物标志物,但尚需进一步验证。
局限性
- 样本量小(16例患者),为观察性研究,无法确立因果关系。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Cases of adolescents and young adults developing myocarditis after vaccination with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-targeted mRNA vaccines have been reported globally, but the underlying immunoprofiles of these individuals have not been described in detail. METHODS: From January 2021 through February 2022, we prospectively collected blood from 16 patients who were hospitalized at Massachusetts General for Children or Boston Children's Hospital for myocarditis, presenting with chest pain with elevated cardiac troponin T after SARS-CoV-2 vaccination. We performed extensive antibody profiling, including tests for SARS-CoV-2-specific humoral responses and assessment for autoantibodies or antibodies against the human-relevant virome, SARS-CoV-2-specific T-cell analysis, and cytokine and SARS-CoV-2 antigen profiling. Results were compared with those from 45 healthy, asymptomatic, age-matched vaccinated control subjects. RESULTS: Extensive antibody profiling and T-cell responses in the individuals who developed postvaccine myocarditis were essentially indistinguishable from those of vaccinated control subjects, despite a modest increase in cytokine production. A notable finding was that markedly elevated levels of full-length spike protein (33.9±22.4 pg/mL), unbound by antibodies, were detected in the plasma of individuals with postvaccine myocarditis, whereas no free spike was detected in asymptomatic vaccinated control subjects (unpaired t test; P<0.0001). CONCLUSIONS: Immunoprofiling of vaccinated adolescents and young adults revealed that the mRNA vaccine-induced immune responses did not differ between individuals who developed myocarditis and individuals who did not. However, free spike antigen was detected in the blood of adolescents and young adults who developed post-mRNA vaccine myocarditis, advancing insight into its potential underlying cause.
引用
- Yonker LM, Swank Z, Bartsch YC, et al. Circulating Spike Protein Detected in Post-COVID-19 mRNA Vaccine Myocarditis. Circulation. 2023. PMID: 36597886. doi:10.1161/CIRCULATIONAHA.122.061025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。